|
|
|
| Biosimilars (2009 - 2014) |
|
| Table of Contents Published: 2009/09 Published by: Markets and Markets |
| The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities in the global biosimilars market. The global biosim ... |
| European Tissue Diagnostics Markets |
|
| Table of Contents Published: 2009/09 Published by: Frost & Sullivan |
| This research service analyses the revenue potential for tissue diagnostics markets in major western European countries. It also gives the overview of the market together with market drivers,restraints and challenges in the whole Europe. ... |
| Competitor Analysis: EGF-R Agonists and Antagonists |
|
| Table of Contents Published: 2009/09 Published by: La Merie |
| The present Competitive Intelligence Report about EGF-R agonists and antagonists provides a competitor evaluation in the field of epidermal growth factor receptor (EGF-R; ErbB1) targeting molecules for wound healing or treatment of cancer as of September ... |
| DNA Vaccines: Technologies and Global Markets |
|
| Table of Contents Published: 2009/09 Published by: BCC Research |
| The study scope includes DNA vaccine products that are commercial or likely to be commercialized within the next 5 years. Both human and animal health markets are studied. DNA vaccine delivery technologies are also included. DNA vaccine candidates in clin ... |
| Cell and Tissue Analysis Products: The Global Market |
|
| Table of Contents Published: 2009/09 Published by: BCC Research |
| This BCC Research report, Cell and Tissue Analysis Products: The Global Market, provides a detailed analysis of the products and technologies that define the market space and summarizes the composition and dynamics of individual companies in the competiti ... |
| Global Biomaterial Market (2009-2014) |
|
| Table of Contents Published: 2009/09 Published by: Markets and Markets |
| The biomaterials market is defined and explained through the introduction of biotechnology and advances in the understanding of human tissue compatibility. Developing from bio-inert materials to biodegradable materials, biomaterials are widely used in med ... |
| Recordati: Pipeline, Products, Performance, Potential |
|
| Table of Contents Published: 2009/09 Published by: Espicom Business Intelligence |
| Pharmaceutical company intelligence reports from Espicom provide a full review of the company' s activities together with five-year sales forecasts for its key products. The company' s financial performance is covered in-depth, from its latest results to ... |
| Monoclonal Antibody Therapeutics 2009-2024 |
|
| Table of Contents Published: 2009/08 Published by: Visiongain |
| Monoclonal antibodies achieved total sales of nearly $32bn in 2008 and have grown rapidly to command over 30% of the global biologic drug market. We expect significant opportunities for further commercial growth from 2009 to 2024, as shown in our new repo ... |
| Molecular Targeted Cancer Therapies Market Forecast |
|
| Table of Contents Published: 2009/08 Published by: Datamonitor |
| Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key brands in these classes face imminent patent ... |
|
|
|
View Cart
Top